Viridian Therapeutics Inc. logo

Viridian Therapeutics Inc. (VRDN)

Market Open
2 Sep, 18:59
NASDAQ (CM) NASDAQ (CM)
$
22. 55
-0.48
-2.0695%
$
2.61B Market Cap
- P/E Ratio
- Div Yield
71,884 Volume
-4.96 Eps
$ 23.03
Previous Close
Analysts:
Add Transaction
Day Range
22.39 23.73
Year Range
13.18 34.29
Want to track VRDN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Viridian Therapeutics Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
HAS
Hayley A. Snell LRI Investments, LLC
46 $845 $870.32 $25.32 3%
Zachary Canonico
Zachary Canonico DIADEMA PARTNERS LP
100,000 $1.84M $2.21M $371,000 20.2%
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
26,641 $541,882.03 $504,047.72 -$37,834.31 -6.98%
YM
Yahya Muhieddine Eleva Capital SAS
7,126 $139,385 $161,047.6 $21,662.6 15.54%
Yuen Man Lee
Yuen Man Lee Persistent Asset Partners Ltd.
25,490 $468,251 $576,119.88 $107,868.88 23.04%
RFL
Rossby Financial LLC Rossby Financial LLC
11 $211 $248.62 $37.62 17.83%